<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Pharmaceutical and Biomedical Research</title>
<title_fa></title_fa>
<short_title>Pharm Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://pbr.mazums.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-4486</journal_id_issn>
<journal_id_issn_online>2423-4494</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.29252/pbr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>11</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>In-silico Analysis and Anti-inflammatory Evaluation of Synthesized Amide Derivatives of Long-chain Fatty Acids</title>
	<subject_fa>داروسازی و طب سنتی</subject_fa>
	<subject>Medicine and traditional medicine</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Original Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Background&lt;/strong&gt;: The search for more active and less toxic anti-inflammatory drugs is the desire of every medicinal chemist. Amide derivatives of fatty acids (FAs) have diverse biological functions.&lt;br&gt;
Objectives: The search for more active and less toxic anti-inflammatory drugs is the desire of every medicinal chemist. Amide derivatives of FAs have diverse biological functions.&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: The current study conducted an in-silico molecular docking analysis using PDB ID: 6DII on synthesized amide derivatives of long-chain FAs (LCFAs) and evaluated and correlated their anti-inflammatory and anti-nociceptive biological mechanisms with those of acetylsalicylic acid as a standard. The synthesis was achieved using glycine, &amp;beta;-alanine, &amp;gamma;-aminobutyric acid (GABA), and palmitoyl chloride. The raw paw edema model was used to assess the anti-inflammatory and analgesic properties.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: The anti-inflammatory assessment revealed a dose-dependent bioactivity from 20 mg/kg to 50 mg/kg; further increments in the dose led to decreased activity. For the analgesic activity, at 100 mg/kg, N-palmitoyl glycine exhibited 83.2% inhibition of writhing compared to 74.3% inhibition of the standard drug, aspirin (100 mg/kg). The molecular docking studies showed that N-palmitoyl alanine had the highest protein binding affinity, followed by N-palmitoyl, GABA, and N-palmitoyl glycine, higher than acetylsalicylic acid. The compounds interacted with the protein via specific functional groups and protein amino acid residues.&lt;br&gt;
&lt;strong&gt;Conclusion&lt;/strong&gt;: The ability of these amide derivatives of LCFAs to biologically inhibit the inflammatory and nociceptive pathways could be attributed to the presence of N-H, C=O, and OH groups, which bind to the GLY-255, THR-300, GLY-302, and ASP-207 residues.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Nociception, Anti-inflammatory Agents, Nociceptive, Carrageenan-induced edema, Molecular mechanisms</keyword>
	<start_page>105</start_page>
	<end_page>114</end_page>
	<web_url>http://pbr.mazums.ac.ir/browse.php?a_code=A-10-820-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Samuel J.</first_name>
	<middle_name></middle_name>
	<last_name>Bunu</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>amuelbunu2@gmail.com</email>
	<code>100319475328460011344</code>
	<orcid>100319475328460011344</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmacy, Niger Delta University, Wilberforce Island, Nigeria.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Haruna</first_name>
	<middle_name></middle_name>
	<last_name>Baba</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>babharun1@gmail.com</email>
	<code>100319475328460011345</code>
	<orcid>100319475328460011345</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmacy, University of Calabar, University of Calabar, Nigeria.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Deghinmotei</first_name>
	<middle_name></middle_name>
	<last_name>Alfred-Ugbenbo</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>audeghinmotei@gmail.com</email>
	<code>100319475328460011346</code>
	<orcid>100319475328460011346</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Bayelsa Medical University, Yenagoa, Nigeria.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
